Results 261 to 270 of about 162,494 (358)

The pharmacokinetics effects of the MCAO model on senkyunolide I in pseudo germ-free rats after oral co-administration of Chuanxiong and warfarin. [PDF]

Front Pharmacol
Li H, Li F, Zhou Y, Xiang Z, Zhou B, Lan B, Ruan X.   +6 more
europepmc   +1 more source

Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats.

, 1982
Taro Ogiso, Masahiro Iwaki, Yoshimasa Konishi   +2 more
openalex   +2 more sources

Refractory anaemia in a patient with end‐stage heart failure secondary to aortic stenosis

ESC Heart Failure, Volume 12, Issue 5, Page 3766-3770, October 2025.
Jiayu Liang, Suxin Luo, Bi Huang
wiley   +1 more source

Assessing Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Incidence of Major Adverse Cardiovascular Events: A Retrospective Cohort Study

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 10, October 2025.
ABSTRACT Purpose Clopidogrel, an antiplatelet agent used to prevent ischemic events, may interact with proton pump inhibitors (PPIs), especially omeprazole and esomeprazole, and reduce its effectiveness. The evidence surrounding this interaction remains controversial.
Aljoharah M. Algabbani, Sumaya N. Almohareb, Adel A. Alrwisan   +2 more
wiley   +1 more source

Warfarin-Induced Pulmonary Hemorrhage: A Rare and Life-Threatening Complication in the Resource-Limited Setting of Gaza. [PDF]

Case Rep Pulmonol
Abu Shammala A, Jaber M, Irfan B, Owda A, Herzallah A.   +4 more
europepmc   +1 more source

PREDICTING WARFARIN DOSAGE

, 1983
S. Dobrzański
openalex   +1 more source

Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 638-653, October 2025.
ABSTRACT Background There are sparse data to guide resumption of direct oral anticoagulants (DOACs) versus warfarin in patients with atrial fibrillation (AF) who survive a major gastrointestinal bleeding (GIB) event. Objective To compare the risk–benefit profile of restarting DOACs versus warfarin among patients with AF following hospitalization for ...
Oluwadolapo D. Lawal, Herbert D. Aronow, Fisayomi Shobayo, Yichi Zhang, Anne L. Hume, Tracey H. Taveira, Kelly L. Matson, Justin Gold, Xuerong Wen   +8 more
wiley   +1 more source

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]

J Clin Med
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 677-687, October 2025.
ABSTRACT Introduction Pediatric plastic bronchitis (PB) is a rare complication of surgically palliated congenital heart disease (CHD). Fibrin casts obstruct airways and can cause respiratory distress. There are no therapeutics approved by the United States Food and Drug Administration to treat PB, but inhaled tissue plasminogen activator (tPA) has been
Kathleen A. Stringer, David Goldberg, Sharon Chen, Philip Thrush, Eric M. Graham, Adam Lubert, Jeffrey Myers, Laura McLellan, Thomas Flott, Samya Nasr, Kurt R. Schumacher   +10 more
wiley   +1 more source

Real-World Evaluation of the Interaction Between Rifampicin and Warfarin: A Retrospective Observational Study. [PDF]

Adv Pharmacol Pharm Sci
Naseralallah L, Nasrallah D, Koraysh S, Al-Qudimat AR.   +3 more
europepmc   +1 more source